Andrew J. Carr

Andrew Jonathan Carr (born 1958 in Bradford, England) is a British surgeon and has been the sixth Nuffield Professor of Orthopaedics[1] and head of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the University of Oxford since 2001.[2]

Carr's research interests are primarily focused on developing and evaluating surgical technologies including joint replacement, arthroscopy and tissue engineering.[3] He has led a number of UK-wide surgical randomized Clinical trials. With colleagues in Oxford he pioneered the involvement of patients in assessing the outcome of orthopaedic operations and has invented a series of patient reported outcome measures (PROMS).[4] The Oxford Scores[5] are now used worldwide in clinical trials and by national joint replacement registries. He works on the effectiveness of surgery in the treatment of chronic musculoskeletal pain including the placebo role of surgical procedures and the importance of central sensitization in persistent post-operative pain.

In 2002 he founded the Botnar Research Centre[6] as an Institute of Musculoskeletal Sciences. In 2008 he led the amalgamation of orthopaedics, rheumatology and musculoskeletal sciences to form a new department at Oxford University. In 2011, the department incorporated the Kennedy Institute of Rheumatology when it moved from Imperial College, London to the University of Oxford.

Carr was appointed founder Director of the National Institute for Health and Care Research (NIHR) Musculoskeletal Biomedical Research Unit (BRU)[7] in Oxford in 2008 and, in 2011, became Divisional Director of the Nuffield Orthopaedic Centre section of the newly formed Oxford University Hospitals NHS Trust. His awards include the Robert Jones Gold medal of the British Orthopaedic Association and a Hunterian Professorship of the Royal College of Surgeons of England. He was elected a fellow of the Academy of Medical Sciences in 2009.